Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 66 of 1714:
56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type II, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel associated protein 1 FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel associated protein 2 FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
cannabinoid receptor 1 (brain) TOLNAFTATE Cannabinoid CB1 50% NoneNone NoneNone View
dopamine receptor D1A SULINDAC SULFIDE Dopamine D1 50% 27.822uM 13.911uM View
mu-opioid receptor MOR SULINDAC SULFIDE Opiate mu 50% 33.668uM 13.667uM View
phosphodiesterase 4A, cAMP specific GENTIAN VIOLET Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific GENTIAN VIOLET Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4D GENTIAN VIOLET Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific GENTIAN VIOLET Phosphodiesterase PDE4 50% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) GENTIAN VIOLET Protein Tyrosine Kinase, HER2 Receptor 50% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) GENTIAN VIOLET Protein Tyrosine Kinase, HER2 Receptor 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
mitogen activated protein kinase 1 VALSARTAN Protein Serine/Threonine Kinase, ERK2 50% NoneNone NoneNone View
mitogen-activated protein kinase 1 VALSARTAN Protein Serine/Threonine Kinase, ERK2 50% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 QUETIAPINE Adrenergic, Norepinephrine Transporter 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TERBINAFINE Calcium Channel Type L, Dihydropyridine 50% NoneNone NoneNone View
progesterone receptor NELFINAVIR Progesterone 50% 44.5uM 5.804uM View
progesterone receptor NELFINAVIR Progesterone 50% 44.5uM 5.804uM View
5-hydroxytryptamine (serotonin) receptor 5B TERCONAZOLE Serotonin 5-HT4 50% 14.78uM 2.463uM View
5-hydroxytryptamine (serotonin) receptor 4 TERCONAZOLE Serotonin 5-HT4 50% 14.78uM 2.463uM View
monoamine oxidase A PROCAINE Monoamine Oxidase MAOA 50% NoneNone NoneNone View
monoamine oxidase A PROCAINE Monoamine Oxidase MAOA 50% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 TACRINE Dopamine Transporter 50% NoneNone NoneNone View
endothelin receptor type A SULFISOXAZOLE Endothelin ETA 50% 21.88uM 13.465uM View
cholinergic receptor, muscarinic 2 ROSIGLITAZONE Muscarinic M2 50% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase GLYPHOSATE CYP450-1A2 Inhibition 50% NoneNone NoneNone View
acetylcholinesterase (YT blood group) PERGOLIDE Acetylcholinesterase 50% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase PERGOLIDE Acetylcholinesterase 50% NoneNone NoneNone View
acetylcholinesterase PERGOLIDE Acetylcholinesterase 50% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase CYPROHEPTADINE CYP450-2D6 Inhibition 50% NoneNone NoneNone View
adenosine A2a receptor ALBENDAZOLE Adenosine A2A 50% NoneNone NoneNone View
Sigma-2 Receptor SULCONAZOLE Sigma2 50% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid A receptor, gamma 1 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid A receptor, pi DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
AT hook, DNA binding motif, containing 1 (DBSS) DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid A receptor, theta DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid A receptor, gamma 2 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid A receptor, alpha 2 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid A receptor, alpha 1 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid A receptor, delta DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 DANAZOL GABAA, Benzodiazepine, Central 50% 54.326uM 44.266uM View
dopamine receptor 2 AMLODIPINE Dopamine D2L 50% NoneNone NoneNone View
Cytochrom P450-2A6 monooxygenase CLOTRIMAZOLE CYP450-2A6 Inhibition 50% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase OMEPRAZOLE CYP450-2C19 Inhibition 50% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase 1-BENZYLIMIDAZOLE CYP450-2C19 Inhibition 50% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase RO 20-1724 CYP450-1A2 Inhibition 50% NoneNone NoneNone View
adrenergic receptor, beta 1 ERGONOVINE Adrenergic beta1 50% NoneNone NoneNone View
adrenergic, beta-1-, receptor ERGONOVINE Adrenergic beta1 50% NoneNone NoneNone View
epidermal growth factor receptor CLOMIPRAMINE Protein Tyrosine Kinase, EGF Receptor 50% NoneNone NoneNone View
melanocortin 4 receptor BENZOTHIAZYL DISULFIDE Melanocortin MC4 50% NoneNone NoneNone View
opioid receptor, delta 1 FLUPHENAZINE Opiate delta 50% 24.036uM 8.473uM View
arachidonate 15-lipoxygenase, second type CAFFEIC ACID PHENETHYL ESTER Lipoxygenase 15-LO 50% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Muscarinic M4 50% NoneNone NoneNone View
adrenergic receptor, beta 2 BW-723C86 Adrenergic beta2 50% NoneNone NoneNone View
adrenergic receptor, alpha 2a TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Adrenergic alpha2A 50% NoneNone NoneNone View
bradykinin receptor, beta 2 TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Bradykinin B2 50% NoneNone NoneNone View
bradykinin receptor B2 TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Bradykinin B2 50% NoneNone NoneNone View
dopamine receptor D3 3,3',5-TRIIODO-L-THYRONINE Dopamine D3 50% NoneNone NoneNone View
caspase 1 HEXACHLOROPHENE Protease, Caspase 1 50% NoneNone NoneNone View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) HEXACHLOROPHENE Protease, Caspase 1 50% NoneNone NoneNone View
caspase 3, apoptosis related cysteine protease HEXACHLOROPHENE Protease, Caspase 1 50% NoneNone NoneNone View
caspase 2 HEXACHLOROPHENE Protease, Caspase 1 50% NoneNone NoneNone View
caspase 7 HEXACHLOROPHENE Protease, Caspase 1 50% NoneNone NoneNone View
caspase 6 HEXACHLOROPHENE Protease, Caspase 1 50% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A 1,3-DIPHENYLGUANIDINE Serotonin 5-HT2A 50% NoneNone NoneNone View
mitogen activated protein kinase 1 GLYBURIDE Protein Serine/Threonine Kinase, ERK2 50% NoneNone NoneNone View
mitogen-activated protein kinase 1 GLYBURIDE Protein Serine/Threonine Kinase, ERK2 50% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific ZAFIRLUKAST Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific ZAFIRLUKAST Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4D ZAFIRLUKAST Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific ZAFIRLUKAST Phosphodiesterase PDE4 50% NoneNone NoneNone View
histamine receptor H 2 DIMENHYDRINATE Histamine H2 50% NoneNone NoneNone View
dopamine receptor D3 METHAPYRILENE Dopamine D3 50% NoneNone NoneNone View
dopamine receptor D1A EPINEPHRINE Dopamine D1 50% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ERGOCORNINE CYP450-2C9 Inhibition 50% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ERGOCORNINE CYP450-2C9 Inhibition 50% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) LOPERAMIDE CYP450-2C9 Inhibition 50% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 LOPERAMIDE CYP450-2C9 Inhibition 50% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase CANDESARTAN CYP450-2C19 Inhibition 50% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase NANDROLONE CYP450-2C19 Inhibition 50% NoneNone NoneNone View
adenosine A2a receptor 4-NONYLPHENOL Adenosine A2A 50% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D TEICOPLANIN Glutamate, NMDA, Agonism 50% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C TEICOPLANIN Glutamate, NMDA, Agonism 50% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B TEICOPLANIN Glutamate, NMDA, Agonism 50% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A TEICOPLANIN Glutamate, NMDA, Agonism 50% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) TEICOPLANIN Glutamate, NMDA, Agonism 50% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B TEICOPLANIN Glutamate, NMDA, Agonism 50% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 ACEMETACIN Cyclooxygenase COX-1 50% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) ACEMETACIN Cyclooxygenase COX-1 50% NoneNone NoneNone View
cathepsin G RIFAPENTINE Protease, Cathepsin G 50% NoneNone NoneNone View
mast cell protease 9 RIFAPENTINE Protease, Cathepsin G 50% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B TENIDAP Serotonin 5-HT2B 50% NoneNone NoneNone View
mitogen activated protein kinase 1 ACEMETACIN Protein Serine/Threonine Kinase, ERK2 50% NoneNone NoneNone View
mitogen-activated protein kinase 1 ACEMETACIN Protein Serine/Threonine Kinase, ERK2 50% NoneNone NoneNone View
caspase 1 DACTINOMYCIN Protease, Caspase 1 50% NoneNone NoneNone View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) DACTINOMYCIN Protease, Caspase 1 50% NoneNone NoneNone View
caspase 3, apoptosis related cysteine protease DACTINOMYCIN Protease, Caspase 1 50% NoneNone NoneNone View
caspase 2 DACTINOMYCIN Protease, Caspase 1 50% NoneNone NoneNone View
caspase 7 DACTINOMYCIN Protease, Caspase 1 50% NoneNone NoneNone View
caspase 6 DACTINOMYCIN Protease, Caspase 1 50% NoneNone NoneNone View
caspase 1 CLOSANTEL Protease, Caspase 1 50% NoneNone NoneNone View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) CLOSANTEL Protease, Caspase 1 50% NoneNone NoneNone View
caspase 3, apoptosis related cysteine protease CLOSANTEL Protease, Caspase 1 50% NoneNone NoneNone View
caspase 2 CLOSANTEL Protease, Caspase 1 50% NoneNone NoneNone View
caspase 7 CLOSANTEL Protease, Caspase 1 50% NoneNone NoneNone View
caspase 6 CLOSANTEL Protease, Caspase 1 50% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CLOSANTEL Adrenergic, Norepinephrine Transporter 50% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 GRAMICIDIN Muscarinic M5 50% NoneNone NoneNone View
dopamine receptor D4 METHYLERGONOVINE Dopamine D4.2 50% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A DOBUTAMINE Serotonin 5-HT2A 50% NoneNone NoneNone View
neuropeptide Y receptor Y2 GRAMICIDIN Neuropeptide Y2 50% NoneNone NoneNone View
neuropeptide Y receptor Y2 GRAMICIDIN Neuropeptide Y2 50% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) ABAMECTIN Protein Tyrosine Kinase, Lck 50% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B LISURIDE Serotonin 5-HT4 50% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 LISURIDE Serotonin 5-HT4 50% NoneNone NoneNone View
androgen receptor IVERMECTIN Testosterone 50% NoneNone NoneNone View
Sigma-2 Receptor S-(-)-PROPRANOLOL Sigma2 49% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SAQUINAVIR Calcium Channel Type L, Dihydropyridine 49% NoneNone NoneNone View